TeleRay is an industry-first telehealth and image management platform. TeleRay cloud-based medical image management platform allows users to securely share images with professionals (specialists, referring, clinicians) and patients. The platform has many features, including the ability to import or convert DICOM or non DICOM images, query and HL7 connectivity. Integrate with any EMR, view images on an FDA approved viewer anywhere on any device.
Complete DICOM image migration is available- set up, training, and implementation is included. Live streaming and remote control of modalities are options and great for many use cases to place professionals virtually in a room any where.
TeleRay is the most secure platform with peer 2 peer health and data communication. You can use the app to access workflow tools like waiting rooms, multi-calls, call transfer and sharing of images. It's simple and affordable.
More than 3000 locations use our service, including 38 of the top medical centers in more than 20 nations. Get started today for free.
Learn more
Athena Security uses advanced concealed weapons detection systems to deliver a unified, AI-driven entryway solution for hospitals, K–12 schools, casinos, places of worship, government buildings, and commercial facilities across the U.S. The Apollo 500 enables seamless walk-through screening to detect weapons in real time, giving operators more actionable data points than traditional systems for faster, more confident decisions. Athena’s AI-powered X-ray leverages iPad technology to modernize screening and improve threat detection.
Athena’s Hospital Visitor Management System integrates with EPIC to connect identity, access, and screening data. Innovations include the Ambulance Bay WDS for stretcher screening and secondary screening for bags and lower extremities to reduce human error. Designed with compliance in mind, Athena aligns with California AB 2975, which mandates weapons detection screening at key hospital entrances by 2027 to improve safety and reduce workplace violence.
DHS-aligned workflows ensure testing, controls, and compliance, while telepresence and AR alert glasses provide real-time support. All systems connect in one platform for centralized monitoring and enterprise reporting.
Learn more
WRRisk
The product evaluates a patient's risk level to create a tailored digital screening plan, ensuring more reliable follow-up recommendations and enhancing diagnostic accuracy. This strategy is particularly effective in identifying cancers in women who are at heightened risk. WRRisk integrates a fully digital breast cancer risk assessment that utilizes patient-completed digital forms alongside a density evaluation to generate a comprehensive risk scorecard. By automating numerous manual processes, such as form collection and letter creation, WRRisk streamlines the management of breast risk programs, eliminating the need for paper documentation. This innovative product empowers both patients and healthcare providers with essential information, enhancing the overall care experience. Additionally, WRRisk provides calculations for ten-year and lifetime risk, as well as assessments based on secondary density metrics.
Learn more
Paige
Paige's offerings have the potential to revolutionize the practice of pathologists by instilling greater certainty in diagnoses. The company is committed to pioneering a new era of clinical tools and predictive assessments that empower pathologists while redefining the field of oncology. With its innovative AI solutions, Paige paves the way for the future of pathology. The Paige Platform serves as a comprehensive, secure solution that ensures interoperability with laboratory information systems (LIS), integrates multiple scanners, offers cloud storage, facilitates case management, enables image review through FullFocus®, and incorporates advanced AI applications. The Paige Prostate suite of AI tools is specifically designed to aid pathologists in identifying suspicious areas, grading and quantifying tissue samples, and assessing perineural invasion (PNI) in prostate needle core biopsies. Similarly, the Paige Breast suite of AI applications supports pathologists in evaluating breast cancer by enabling the identification of malignancies in breast biopsies and the detection of metastases in lymph nodes associated with breast tissue. Collectively, these advancements not only enhance diagnostic accuracy but also improve patient outcomes in oncology.
Learn more
